Factors Determining the Prognosis in NSCLC Stage IV

NCT04306094 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 217

Last updated 2020-03-12

No results posted yet for this study

Summary

This study is a cohort study with patients with advanced NSCLC. Patients will answer questionnaires about symptoms and quality of life and will be submitted to physical and blood tests, and computer tomography. The aim of this study is to estimate prognostic factors predicting survival to 3 months in patients with advanced NSCLC.

Conditions

  • NSCLC Stage IV

Sponsors & Collaborators

  • Instituto do Cancer do Estado de São Paulo

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-01
Primary Completion
2021-12-31
Completion
2022-02-01

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04306094 on ClinicalTrials.gov